Universidad de La Laguna-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2014

  1. Striatal vessels receive phosphorylated tyrosine hydroxylase-rich innervation from midbrain dopaminergic neurons

    Frontiers in Neuroanatomy, Vol. 8, Núm. AUG

2009

  1. Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease

    Neurobiology of Disease, Vol. 36, Núm. 3, pp. 494-508

2006

  1. Consequences of unilateral nigrostriatal denervation on the thalamostriatal pathway in rats

    European Journal of Neuroscience, Vol. 23, Núm. 8, pp. 2099-2108

2005

  1. Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells

    European Journal of Neuroscience, Vol. 21, Núm. 7, pp. 1815-1827

2004

  1. How does Parkinson's disease begin? The role of compensatory mechanisms (multiple letters)

    Trends in Neurosciences

  2. The origin of motor fluctuations in Parkinson's disease: Importance of dopaminergic innervation and basal ganglia circuits

    Neurology, Vol. 62, Núm. 1 SUPPL. 1

2000

  1. Pathophysiology of the basal ganglia in Parkinson's disease

    Trends in Neurosciences, Vol. 23, Núm. 10 SUPPL.